Whole-Genome Sequencing Accurately Identifies Resistance to Extended-Spectrum β-Lactams for Major Gram-Negative Bacterial Pathogens
Author(s) -
Samuel A. Shelburne,
Jiwoong Kim,
José M. Munita,
Pranoti Sahasrabhojane,
Ryan K. Shields,
Ellen G. Press,
Xiqi Li,
César A. Arias,
Brandi L. Cantarel,
Ying Jiang,
Min S. Kim,
Samuel L Aitken,
David E. Greenberg
Publication year - 2017
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cix417
Subject(s) - whole genome sequencing , medicine , broth microdilution , genotype , antibiotic resistance , polymerase chain reaction , drug resistance , gold standard (test) , dna sequencing , microbiology and biotechnology , antibiotics , gene , genome , biology , minimum inhibitory concentration , genetics
There is marked interest in using DNA-based methods to detect antimicrobial resistance (AMR), with targeted polymerase chain reaction (PCR) approaches increasingly being incorporated into clinical care. Whole-genome sequencing (WGS) could offer significant advantages over targeted PCR for AMR detection, particularly for species where mutations are major drivers of AMR.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom